Status:

COMPLETED

Aprepitant for PONV Prophylaxis in Outpatient Plastic Surgery

Lead Sponsor:

University of Pittsburgh

Collaborating Sponsors:

Merck Sharp & Dohme LLC

Conditions:

Postoperative Nausea and Vomiting

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

Hypothesis: Aprepitant plus ondansetron is more effective than ondansetron plus placebo for prevention of postoperative emesis in patients at moderate-to-high risk for PONV for up to 48 hours after su...

Detailed Description

We plan to enroll women and men undergoing outpatient plastic surgical procedures under general anesthesia. Patients who are scheduled for outpatient plastic surgery will be contacted by one of the in...

Eligibility Criteria

Inclusion

  • Written informed consent
  • ASA (American Society of Anesthesiologists physical status) 1-3
  • Male and female Age 18 to 65 years
  • Plastic surgical procedure (Breast, Face, Liposuction, etc., and excluding peripheral procedures such as hand surgery and limited-scope split-thickness skin grafts) of at least 1 hour in duration
  • General anesthesia
  • Presence of 2 (men)/3 (women) or more risk factors for PONV
  • Ambulatory surgery with same-day discharge planned

Exclusion

  • Patient refusal
  • Patients who have received other antiemetics prior to their procedure
  • History of allergy or sensitivity to study drugs
  • Pregnancy - Patients are asked date of last menstrual period, use of birth control, tubal ligation, if they have had unprotected sexual intercourse and if they think if there is any possibility of being pregnant, and when appropriate, a pregnancy test will be obtained which is the standard of care at Magee-Womens Hospital.
  • Patients with a history of chronic opioid use (chronic pain syndrome) as these patients will be less likely to have PONV

Key Trial Info

Start Date :

June 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2010

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT00659945

Start Date

June 1 2008

End Date

June 1 2010

Last Update

February 6 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UPMC Magee Women's Hospital

Pittsburgh, Pennsylvania, United States, 15213

Aprepitant for PONV Prophylaxis in Outpatient Plastic Surgery | DecenTrialz